Compare WVE & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | CASH |
|---|---|---|
| Founded | 2012 | 1954 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2015 | 1996 |
| Metric | WVE | CASH |
|---|---|---|
| Price | $7.25 | $87.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 2 |
| Target Price | $29.50 | ★ $107.50 |
| AVG Volume (30 Days) | ★ 6.4M | 155.7K |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | N/A | ★ 18.88 |
| EPS | N/A | ★ 1.57 |
| Revenue | $3,704,000.00 | ★ $839,894,000.00 |
| Revenue This Year | N/A | $7.56 |
| Revenue Next Year | $85.67 | $6.02 |
| P/E Ratio | ★ N/A | $62.85 |
| Revenue Growth | ★ 149.43 | 11.29 |
| 52 Week Low | $5.02 | $65.93 |
| 52 Week High | $21.73 | $101.26 |
| Indicator | WVE | CASH |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 36.77 |
| Support Level | $6.93 | $87.19 |
| Resistance Level | $7.67 | $94.84 |
| Average True Range (ATR) | 0.33 | 2.88 |
| MACD | 0.23 | -0.29 |
| Stochastic Oscillator | 47.80 | 20.53 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.